NABI /DE/
424B3, 1997-03-12
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NEWPARK RESOURCES INC, PRE 14A, 1997-03-12
Next: MOVADO GROUP INC, SC 13G/A, 1997-03-12



<PAGE>   1
PROSPECTUS SUPPLEMENT                          Filed pursuant to Rule 424(b)(3)
To Prospectus Dated May 3, 1996,                      Registration No. 333-2253
As Supplemented to Date


                                 $80,500,000


                                     NABI


                6 1/2% Convertible Subordinated Notes due 2003
                                     and
              Shares of Common Stock, Par Value $.10 Per Share,
                       Issuable Upon Conversion Thereof


        This Prospectus Supplement (the "Supplement") relates to the resale by
Kapor Family Foundation of up to $100,000 aggregate principal amount of 6 1/2%
Convertible Subordinated Notes due 2003 (the "Notes") of NABI, a Delaware
corporation (the "Company"), originally issued in private placements
consummated on February 7 and March 6, 1996 (the "Debt Offering"), pursuant to
NABI's Registration Statement on Form S-3 (No. 333-2253) (the "Registration
Statement"). This Supplement should be read in conjunction with the Prospectus
dated May 3, 1996, as supplemented to date (the "Prospectus"), to be delivered
with this Supplement. All capitalized terms used but not defined in this
Supplement shall have the meanings given them in the Prospectus.

        Based on information provided to the Company, the aggregate principal
amount of the Notes that are currently beneficially owned by Kapor Family
Foundation is $100,000, of which all may be sold at this time pursuant to the
Prospectus as supplemented hereby. Additional information concerning the
Selling Securityholders (including Kapor Family Foundation) may be set forth
from time to time in additional supplements to the Prospectus. The total
outstanding aggregate principal amount of the Notes is $80,500,000.

        The closing price of the Company's Common Stock as reported on The
Nasdaq National Market on March 5, 1997 was $10.125 per share.

        The Notes will be subordinated to all existing and future Senior
Indebtedness of the Company. At December 31, 1996, Senior Indebtedness was
approximately $2,400,000. The Indenture contains no limitations on the
incurrence of additional indebtedness or other liabilities by the Company.

        The Notes are neither listed on a national securities exchange nor
quoted on an automated quotation system. However, the Notes are eligible for
trading in the Private Offerings, Resales and Trading through Automated
Linkages ("PORTAL") Market. Notes sold pursuant to the Registration Statement
will no longer be eligible for trading in the PORTAL Market.

           The date of this Prospectus Supplement is March 6, 1997.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission